Research collaboration uses cutting-edge technology to produce new veterinary drug

May 15, 2018, Victoria University of Wellington

Researchers from Victoria University of Wellington's Ferrier Research Institute, Callaghan Innovation, the University of Canterbury, and Massey University have developed cutting-edge gene engineering technology to help scientists more efficiently manipulate DNA in order to produce new products, including a new veterinary drug.

Ferrier Research Institute researchers have used this novel technology to produce a new flea treatment for domestic pets by manipulating a compound called nodulisporic A.

"When used in insecticides, nodulisporic acid A is very effective at controlling fleas and ticks in domestic pets, but it is currently difficult to produce," says Kyle van de Bittner, a Ph.D. student at Ferrier Research Institute. "It is naturally produced in small quantities by a type of fungus, but until now the complexity of the compound and the fungus have prevented scientists from producing the compound in greater quantities. This has greatly impeded any development of drugs that include nodulisporic acid A."

Using the new gene engineering technology, Ferrier staff have been able to better understand the compound and take the first steps towards producing it in greater quantities. They have identified the involved in producing an early stage of nodulisporic acid A, and been able to transfer those genes into a different fungus. This fungus grows quickly and has biological qualities which help speed up the process of making nodulisporic acid A.

There are additional advantages to the method.

"Rather than relying on toxic solvents typically used in the chemical synthesis of compounds like this, we use sugar water to grow the fungi to create the ," Kyle says. "This is cheaper and more environmentally-friendly than current methods."

Ferrier staff plan to continue development of the compound. They are also working with Matt Nicholson at VicLink, Victoria University's commercialisation arm, to create a commercial product based on their work. The commercialisation work is funded by Kiwinet.

"This is just the beginning," Kyle says. "We still have a great deal of work to do to finalise the production of our key chemical target, nodulisporic acid A, and optimise the fungus to make more of it. But the science is delivering and we are inspired to push the limits of what is possible."

The new veterinary medicine was made possible by a novel technology called MIDAS (Modular Idempotent DNA Assembly System). MIDAS is a system that gives scientists more control over the DNA they manipulate during their research, resulting in a faster and more efficient way to make new pharmaceuticals, biofuels, antibodies, and more.

"Using MIDAS, scientists can more rapidly assemble new genes from a library of DNA parts," says Callaghan Innovation scientist Dr. Craig van Dolleweerd, who designed the MIDAS technology. "They can quickly test what the new genes do, and how they interact with other genes. This will greatly speed up research into the discovery of new biochemical pathways and the manufacture of new synthetic biology products, which includes everything from biofuels to fragrances."

An article about the MIDAS technology was recently published in ACS Synthetic Biology, a leading journal in the new area of synthetic biology, and the nodulisporic acid A research appeared in the Journal of the American Chemical Society, the highest ranked chemistry journal in the world.

There are patents pending on both the MIDAS and the production of nodulisporic acid A, both of which have been developed with funding from the Ministry of Business, Innovation, and Employment and Fulbright NZ.

Explore further: 'Rewriting' the way to make natural drug compounds

Related Stories

'Rewriting' the way to make natural drug compounds

November 6, 2014

One of the big hurdles in bringing drugs to market is the difficulty of producing large enough quantities of potential compounds to conduct clinical trials. This is particularly true with compounds made by organisms, which ...

A path away from reliance on oil

May 18, 2016

The dream of replacing petrochemicals with renewable resources in the manufacture of synthetic fibers and plastics has moved a step closer. A*STAR researchers have genetically modified the bacterium Escherichia coli to produce ...

Chemical engineers boost bacteria's productivity

February 13, 2017

MIT chemical engineers have designed a novel genetic switch that allows them to dramatically boost bacteria's production of useful chemicals by shutting down competing metabolic pathways in the cells.

Recommended for you

Archaeologists discover Incan tomb in Peru

February 16, 2019

Peruvian archaeologists discovered an Incan tomb in the north of the country where an elite member of the pre-Columbian empire was buried, one of the investigators announced Friday.

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...

What rising seas mean for local economies

February 15, 2019

Impacts from climate change are not always easy to see. But for many local businesses in coastal communities across the United States, the evidence is right outside their doors—or in their parking lots.

The friendly extortioner takes it all

February 15, 2019

Cooperating with other people makes many things easier. However, competition is also a characteristic aspect of our society. In their struggle for contracts and positions, people have to be more successful than their competitors ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.